Epidemiological, Clinical, Histological, Serological and Therapeutic Study of Children Celiac Disease in Western Algeria Region
Objectives: To determine the epidemiological, clinical, histological, serological and therapeutic profile of celiac disease in children in Western Algeria region.Methods: 250 patients over a period of three years (2016 - 2019) from the pediatric department of the University Hospital of Oran (West Algeria) were included in our retrospective study.Results: We noticed a female predominance with a sex ratio F/M = 1.57. Symptoms were defined by typical (73.2%) and atypical (26.8%) forms, digestive disorders (47.2%), extra digestive disorders (14.4%). Anemia was noted at 73.6%, and the association with autoimmune diseases at 14.8%. Seropositivity was present in 77.6% of cases and histology revealed partial grade villous atrophy at 54%. We noticed a significant link between the histological grade and the serology (p = 0.001), between age and histological grade (p<10-3), between bone age and body mass index (p = 0.017), between the age of onset of the disease and the age of food diversification (p = 0.030), and with the age of breastfeeding (p = 0.026). In addition, we found an excellent correlation between anti-transglutaminase and anti-endomysium autoantibodies during diagnosis and under diet (p<10-3), and between serology during diagnosis and serology under diet (p = 0.002)Conclusion: Celiac disease (CD) of children in western Algeria is characterized by a variety of clinical symptoms. The gluten-free diet remains the only therapy for these affected children.
Keywords: celiac disease, children, epidemiology, serology, histology, associated diseases, treatment.
2. Husby S, Koletzko S, Korponay-Szabó IR, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease , J. Pediatr. Gastroenterol. Nutr, 2012; 54(1):136-160.
3. M. F. Kagnoff. Celiac disease:pathogenesis of a model immunogenetic disease . J. Clin. Invest, 2007; 117(1):41-49.
4. Green FHR et C. Cellier. Celiac disease . N. Engl. J. Med. 2007; 357(17):1731-1743.
5. Mäki M, Mustalahti K, Kokkonen J, et al. Prevalence of Celiac disease among children in Finland. N Engl J Med. 2003; 348(25):2517-2524.
6. Myléus A, Ivarsson A, Webb C, et al. Celiac disease revealed in 3% of Swedish 12-year-olds born during an epidemic. J Pediatr Gastroenterol Nutr. 2009;49(2):170-176.
7. Catassi C et al. Coeliac disease in the year2000:exploring the iceberg. Lancet, 1994; 343:200-203.
8. Korponay-Szabó IR, Szabados K, Pusztai J, et al. Population screening for coeliac disease in primary care by district nurses using a rapid antibody test: diagnostic accuracy and feasibility study. BMJ. 2007; 335 (7632):1244-1247.
9. Catassi C et al. Why is coeliac disease endemic in the people of the Sahara? . Lancet, 1999; 354(9179):647-648.
10. Fasano A et C. Catassi. Coeliac disease in children . Best PractRes Clin Gastroenterol, 2005; 19(3):467-478.
11. Saeed A, Assiri AM, et H. A. Cheema. Celiac Disease in Children ,2019 ; 2(1):6.
12. Verkarre V, et N. Brousse. Le diagnostic histologique de la maladie cœliaque . Pathologie Biologie, 2013; 61(2):e13-e19.
13. S. J. Gluten-free diet for children. Pathologie-biologie, 2013.
14. Kivelä L, Kaukinen K, Lähdeaho ML, et al. Presentation of Celiac Disease in Finnish Children Is No Longer Changing: A 50-Year Perspective. J Pediatr. 2015; 167(5):1109-15.e1.
15. Abed N, N. el houdaCherouat, H. Mohammedi, A. Rouabah, et L. Rouabah. Characteristics of Celiac Disease in Childhood of Eastern Algeria. Advanced Research in Life Sciences, 2019; 3(1):5-10.
16. McNeish AS, Harms HK, Rey J, Shmerling DH, Visakorpi JK, Walker-Smith JA. The diagnosis of coeliac disease. A commentary on the current practices of members of the European Society for Paediatric Gastroenterology and Nutrition (ESPGAN). Arch Dis Child. 1979; 54(10):783-786.
17. H. Garnier-Lengliné, G. Malamut, N. Cerf-Bensussan, et F. M. Ruemmele. Treatment perspectives. Pathol. Biol, 2013; 61( 3): e61-64.
18. Ludvigsson JF et al. The Oslo definitions for coeliac disease and relatedterms . Gut, 2013; 62(1):43-52.
19. A. K. Ahmed, R. M. A. Elhafiz, A. S. Almubarak, et M. A. Ali. Frequency Rate of Celiac Disease in Sudanese Patients presenting with Chronic Diarrhea . African Journal of Medical Sciences, 2018; 3(4).
20. Hill ID, Dirks MH, Liptak GS, et al. Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2005; 40(1):1-19.
21. F. Boukezoula, S. Smaali, et M. Zidoune. Prevalence of Anemia in a Population with Celiac Disease in Tébessa (Algeria), 2018; 5.
22. A. Albrady. Clinical Profile of Celiac Disease: Patient Epidemiological Prospective . Annals of Medical and Health Sciences Research, 2018; 8(1):5.
23. J. Cosnes et I. Nion-Larmurier. Les complications de la maladie cœliaque .Pathologie Biologie, 2013; 61(2):e21-e26.
24. Lauret E et L. Rodrigo. Celiac Disease and Autoimmune-Associated Conditions .BiomedRes Int, 2013; 2013.
25. Castro-Antunes MM, Magalhães R, Nobre JMM, Silva BP, et G. A. P. Silva. Celiac disease in first-degree relatives of patients . J Pediatr (Rio J), 2010; 86(4):331-336.
26. AGA Institute. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology, 2006; 131(6):1977-1980.
27. Roujonet P al. Diagnostic sérologique de la maladie cœliaque .Pathologie Biologie, 2013; 61(3):e39-e46.
28. Farrell RJ, et C. P. Kelly. Celiac sprue . N. Engl. J. Med, 2002; 346(3):80-188.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).